Autologous hinge as a universal antibody lock enhance the selectivity and safety of antibody drug

Authors

  • Yun-Chi LU Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
  • ian-Lu CHENG Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
  • Chih-Hung CHUANG Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan
  • Wen-Wei LIN Department of Laboratory Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Keywords:

on-target toxicities, “antibody lock”, Remicade

Abstract

Autologous hinge as a universal antibody lock enhance the selectivity and safety of antibody drug

Author Biographies

ian-Lu CHENG, Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan

Professor, Director

Chih-Hung CHUANG, Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan

Assistant Professor

Downloads

Published

2019-07-17

How to Cite

LU, Y.-C., CHENG, ian-L., CHUANG, C.-H., & LIN, W.-W. (2019). Autologous hinge as a universal antibody lock enhance the selectivity and safety of antibody drug. Vestnik of the Far East Branch of the Russian Academy of Sciences, (6s), 114. Retrieved from http://vestnikdvo.ru/index.php/vestnikdvo/article/view/353

Issue

Section

Статьи